![]() |
市場調査レポート
商品コード
1519735
銀創傷被覆材市場レポート:タイプ、疾患、エンドユーザー、地域別、2024年~2032年Silver Wound Dressing Market Report by Type, Disease, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
銀創傷被覆材市場レポート:タイプ、疾患、エンドユーザー、地域別、2024年~2032年 |
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
銀創傷被覆材の世界市場規模は、2023年に9億7,010万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億8,670万米ドルに達し、2024年から2032年の間に4%の成長率(CAGR)を示すと予測しています。
銀創傷被覆材とは、創傷に一定量の銀を放出し、抗菌・殺菌作用を発揮する局所創傷ケア製品を指します。バリア層、チャコールクロスドレッシング、フォームドレッシング、ハイドロコロイドなどの形態で広く販売されています。銀ドレッシング材は、手術創、熱傷、褥瘡、下腿潰瘍、糖尿病性足潰瘍などの急性および慢性創傷において、滲出液が最小限、中程度、または多量の場合に、一次または二次ドレッシング材として使用することができます。銀創傷被覆材はまた、圧迫下または選択された局所療法や補助療法と併用することで、細菌負荷を軽減し、滲出液を封じ込め、創傷の肉芽組織の外観を改善することができます。近年、銀創傷被覆材は、局所感染や生物負荷のリスクがある急性または慢性の創傷を治療するために、ヘルスケア業界で絶大な人気を博しています。
銀創傷被覆材は感染症の予防と軽減に役立ち、幅広い抗菌活性を提供し、創傷内のメタロプロテアーゼを変化させる。その結果、銀創傷被覆材は従来の創傷ケアや創傷閉鎖製品に取って代わりつつあり、これが市場成長を牽引する主な要因となっています。このほか、慢性創傷や火傷の増加、高度な創傷治療に対する意識の高まりが、銀創傷被覆材の需要を喚起しています。さらに、がん、糖尿病、心血管疾患(CVD)などの慢性疾患の有病率が大幅に増加しています。これとともに、手術を受ける患者の増加が、手術部位感染を防ぎ、創傷治癒を早める銀創傷被覆材の採用を後押ししています。さらに、いくつかの主要プレーヤーは、製品ポートフォリオを拡大し、競争力を得るために、新しく革新的な銀創傷被覆材を発売するために多額の投資を行っています。また、在宅医療の台頭、交通事故の増加、高齢化、ヘルスケアインフラの改善、技術の進歩、広範な研究開発活動などのその他の要因も市場成長を後押ししています。
The global silver wound dressing market size reached US$ 970.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,386.7 Million by 2032, exhibiting a growth rate (CAGR) of 4% during 2024-2032.
Silver wound dressings refer to topical wound care products that release a steady amount of silver to the wound to provide antimicrobial and antibacterial action. They are widely available in the form of barrier layers, charcoal cloth dressings, foam dressings, and hydrocolloids. Silver dressings can be used as primary or secondary dressings to manage minimal, moderate, or heavy exudate in acute and chronic wounds, such as surgical wounds, burns, pressure ulcers, leg ulcers, and diabetic foot ulcers. They can also be utilized under compression or with select topical and adjunctive therapies to reduce the bacterial load, contain exudate, and improve the appearance of the wound's granulation tissue. In recent years, silver wound dressings have gained immense popularity in the healthcare industry to treat acute or chronic wounds with or at risk of local infection or bioburden.
Silver wound dressings help prevent and reduce infections, provide a wide range of antimicrobial activity, and alter metalloproteinases within wounds. As a result, silver wound dressings are rapidly replacing traditional wound care and closure products, which represents the primary factor driving the market growth. Besides this, the rising incidences of chronic wounds and burns and the growing awareness regarding advanced wound care treatment are catalyzing the demand for silver wound dressings. Additionally, there has been a significant increase in the prevalence of chronic conditions, such as cancer, diabetes, and cardiovascular diseases (CVDs). Along with this, the increasing number of patients undergoing surgeries is encouraging the adoption of silver wound dressings to prevent surgical site infections and promote faster wound healing. Furthermore, several key players are making heavy investments to launch new and innovative silver wound dressing variants to expand their product portfolio and gain a competitive edge. Other factors, including the emerging trend of home healthcare, rising cases of road accidents, aging population, improving healthcare infrastructure, technological advancements, and extensive research and development (R&D) activities, are also providing a positive thrust to the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global silver wound dressing market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, disease and end user.
Hydrofiber Silver Dressings
Nanocrystalline Silver Dressing
Silver Plated Nylon Fiber Dressing
Silver Nitrate Dressing
Silver Alginate Dressing
Others
Ulcers
Burns
Cuts and Lacerations
Others
Inpatient Facilities
Outpatient Facilities
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, ConvaTec Group plc, Ferris Mfg. Corp., Hollister Incorporated, Integra LifeSciences, Medline Industries LP, Molnlycke Health Care AB and Smith & Nephew plc.